Effect of GNRH Agonist and LNG-IUS for Treatment of Adenomyosis

doi:10.21608/ejhm.2024.379922

Home Articles List Article Information

|
|
|
How to cite
RIS EndNote BibTeX APA MLA Harvard Vancouver
|
Share

The Egyptian Journal of Hospital Medicine

Articles in Press

Current Issue

Journal Archive

Volume 99 (2025)

Volume 98 (2025)

Volume 100 (2025)

Volume 97 (2024)

Volume 96 (2024)

Issue 1

Volume 95 (2024)

Volume 94 (2024)

Volume 93 (2023)

Volume 92 (2023)

Volume 91 (2023)

Volume 90 (2023)

Volume 89 (2022)

Volume 88 (2022)

Volume 87 (2022)

Volume 86 (2022)

Volume 85 (2021)

Volume 84 (2021)

Volume 83 (2021)

Volume 82 (2021)

Volume 81 (2020)

Volume 80 (2020)

Volume 79 (2020)

Volume 78 (2020)

Volume 77 (2019)

Volume 76 (2019)

Volume 75 (2019)

Volume 74 (2019)

Volume 73 (2018)

Volume 72 (2018)

Volume 71 (2018)

Volume 70 (2018)

Volume 69 (2017)

Volume 68 (2017)

Volume 67 (2017)

Volume 66 (2017)

Volume 65 (2016)

Volume 64 (2016)

Volume 63 (2016)

Volume 62 (2016)

Volume 61 (2015)

Volume 60 (2015)

Volume 59 (2015)

Volume 58 (2015)

Volume 57 (2014)

Volume 56 (2014)

Volume 55 (2014)

Volume 54 (2014)

Volume 53 (2013)

Volume 52 (2013)

Volume 51 (2013)

Volume 50 (2013)

Volume 49 (2012)

Volume 48 (2012)

Volume 47 (2012)

Volume 46 (2012)

Volume 45 (2011)

Volume 44 (2011)

Volume 43 (2011)

Volume 42 (2011)

Volume 41 (2010)

Volume 40 (2010)

Volume 39 (2010)

Volume 38 (2010)

Volume 37 (2009)

Volume 36 (2009)

Volume 35 (2009)

Volume 34 (2009)

Volume 33 (2008)

Volume 32 (2008)

Volume 31 (2008)

Volume 30 (2008)

Volume 29 (2007)

Volume 28 (2007)

Volume 27 (2007)

Volume 26 (2007)

Volume 25 (2006)

Volume 24 (2006)

Volume 23 (2006)

Volume 22 (2006)

Volume 21 (2005)

Volume 20 (2005)

Volume 19 (2005)

Volume 18 (2005)

Volume 17 (2004)

Volume 16 (2004)

Volume 15 (2004)

Volume 14 (2004)

Volume 13 (2003)

Volume 12 (2003)

Volume 11 (2003)

Volume 10 (2003)

Volume 9 (2002)

Volume 8 (2002)

Volume 7 (2002)

Volume 6 (2002)

Volume 5 (2001)

Volume 4 (2001)

Volume 3 (2001)

Volume 2 (2001)

Volume 1 (2000)

	Effect of GNRH Agonist and LNG-IUS for Treatment of Adenomyosis
Article 116, Volume 96, Issue 1, July 2024, Page 3123-3128 PDF (289.53 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2024.379922
View on SCiNiTO
Abstract
Background:Uterine adenomyosis is a chronic condition that is dependent on estrogen and affects approximately 20% of gynaecology patients. Dysmenorrhea, menorrhagia, and an enlarged uterus are commonly observed adenomyosis clinical symptoms.Objective: This study aimed to assess levonorgestrel-releasing intrauterine system (LNG-IUS) and gonadotropin-releasing hormone agonist (GnRH-a) effectiveness for adenomyosis symptoms improvement. Methods:This case-control study wascarried out on 60 women with adenomyosis who had regular follow-up examinations. The patients were categorized into 2 equal groups: Case group (group 1 receiving GnRH-a as well as LNG-IUS) and control group (group 2 receiving GnRH-a only). The indices observed included: Serum CA125 level during, before and after the treatment, hemoglobin value before and 3 months after treatment, verbal rating scale (VRS), visual analogue scale (VAS), and uterine volume. Results: After treatment, the Hb level was significantly elevated in the case group compared to the control group (P=0.035), whereas CA125 was significantly lower in the case group compared to the control group (P=0.009). Regarding the clinical assessment, after treatment, the dysmenorrhea VRS score, and the dysmenorrhea VAS score were significantly reduced in the case group compared to the control group (P<0.05). Conclusions: Both LNG-IUS and GnRH-a combination treatment is efficient and safe in adenomyosis and caused a significant reduction in serum CA125 and dysmenorrhea.
Keywords
GnRH agonist; LNG- IUS; Adenomyosis


Statistics Article View: 184 PDF Download: 133